The Neovasc Inc (NASDAQ: NVCN) stock was on fire on Tuesday after the company was awarded a patent by the relevant authorities in Europe. After the news came through, the stock managed to record considerable gains yesterday.
After soaring by 55% on Tuesday and the stock jumped as high as 25% during premarket trading. Considering the gains made by the stock, it could be a wise move for investors to keep an eye on the stock over the course of the coming days.
The patent in question is titled “sequentially deployed transcatheter mitral valve prosthesis” and it is going to be closely watched how the patent is actually deployed by Neovasc. In addition to that, the stock received another boost on Tuesday after it emerged that the Neovasc stock regained compliance with the minimum bid price requirements for NASDAQ. That means that the stock is no longer in any imminent danger of being delisted.